01 4Boehringer Ingelheim (Canada) Ltd.
01 12435730
02 12496249
03 12649922
04 12651019
01 4Linagliptin
01 4Tablet
01 12022-02-21
02 12023-08-18
03 12027-04-30
04 12027-05-03
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Brand Name : TRAJENTA
Patent Number : 2435730
Filing Date : 2002-02-21
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Patent Expiration Date : 2027-04-30
Date Granted : 2014-02-04
Brand Name : TRAJENTA
Patent Number : 2649922
Filing Date : 2007-04-30
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-04-30
Date Granted : 2014-02-04
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Brand Name : TRAJENTA
Patent Number : 2496249
Filing Date : 2003-08-18
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
Brand Name : TRAJENTA
Patent Number : 2651019
Filing Date : 2007-05-03
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
